Motilal Oswal Bse Healthcare Etf
(An open ended fund replicating / tracking the BSE Low Volatility Total Return Index
-
fundIcon:/content/dam/motilal-mf/fund-icons/MO_BSE_Healthcare_ETF.svg
-
dateAsOn:31 Mar 2026
-
schDetail:
- cmotsGroupCode: MO42978
- nfoStartDate: 13-Jul-2022
- dateOfAllotment: 2022-07-29
- sebiCategory: ETF Fund
- schemeName: Motilal Oswal Bse Healthcare Etf
- nfoEndDate: 21-Jul-2022
- fundCategoryCode: ETF
- schcode: SH
-
minamount:
-
0:
- minredamt: NULL
- minsipamt: NULL
- minpuramt: NULL
- minaddpuramt: NULL
- optioncode: G
- plancode: GR
-
-
fundsTaggingSection:
- 0: motilal-oswal-amc:indian-equity-
- 1: motilal-oswal-amc:sector
- 2: motilal-oswal-amc:etf
-
planList:
-
0:
- groupedName: Regular-Growth
- planName: Regular
- optionCode: G
- groupedCode: GRG
- planNameOriginal: Regular Growth
- planCode: GR
- sixth_char_name: R
- optionName: Growth
- schDetail:
- fundCategoryCode:
- cfReferencePath: /content/dam/motilal-mf/content-fragment/plan-code-model-fragment/regular-growth-etf
- isin: INF247L01BB1
- amfi_schcode: 150445
- cmt_schcode: 42978
-
-
nav:
-
0:
- latnav: 42.3026
- optioncode: G
- plancode: GR
- prodcode: SHGR
- nav_date: 23-Jan-2026
- nav_amount: 41.79
-
-
returns:
-
0:
- oneYear_Ret: 1.17
- oneYear_marketValue: 10117.141162514827
- threeYear_Ret: 24.43
- threeYear_marketValue: 19265.05815595085
- inception_Ret: 18.18
- inception_marketValue: 18471.460509309396
- latNavDate: 2026-03-31
- prodcode: SHGR
- plancode: GR
- optioncode: G
- amfi_schcode: 150445
- cmt_schcode: 42978
- isin: INF247L01BB1
-
Call back
Share
Historical Performance
CAGR
planList:
-
0:
- groupedName: Regular-Growth
- planName: Regular
- optionCode: G
- groupedCode: GRG
- planNameOriginal: Regular Growth
- planCode: GR
- sixth_char_name: R
- optionName: Growth
- schDetail:
- fundCategoryCode:
- cfReferencePath: /content/dam/motilal-mf/content-fragment/plan-code-model-fragment/regular-growth-etf
- isin: INF247L01BB1
- amfi_schcode: 150445
- cmt_schcode: 42978
-
returns:
-
0:
- oneYear_Ret: 1.17
- oneYear_marketValue: 10117.141162514827
- threeYear_Ret: 24.43
- threeYear_marketValue: 19265.05815595085
- inception_Ret: 18.18
- inception_marketValue: 18471.460509309396
- latNavDate: 2026-03-31
- prodcode: SHGR
- plancode: GR
- optioncode: G
- amfi_schcode: 150445
- cmt_schcode: 42978
- isin: INF247L01BB1
-
Tracking Difference
Data as on 27 Feb 2026
- 1Y
- 3Y
- 5Y
- 10Y
- Inception
Scheme Inception Date -29-09-2023.
Performance is based on Compounded Annualised returns
Tracking Difference shall be disclosed only if the Scheme has completed 1 year
period
Tracking Difference is the difference in the performance between Scheme and its Benchmark
Periodic Returns
Data as on 31 Mar 2026
- 1Y
- 3Y
- 5Y
- 7Y
- 10Y
- Inception
-
schemeName: Motilal Oswal Bse Healthcare Etf
-
planList:
-
0:
- groupedName: Regular-Growth
- planName: Regular
- optionCode: G
- groupedCode: GRG
- planNameOriginal: Regular Growth
- planCode: GR
- sixth_char_name: R
- optionName: Growth
- schDetail:
- fundCategoryCode:
- cfReferencePath: /content/dam/motilal-mf/content-fragment/plan-code-model-fragment/regular-growth-etf
- isin: INF247L01BB1
- amfi_schcode: 150445
- cmt_schcode: 42978
-
-
returns:
-
0:
- oneYear_Ret: 1.17
- oneYear_marketValue: 10117.141162514827
- threeYear_Ret: 24.43
- threeYear_marketValue: 19265.05815595085
- inception_Ret: 18.18
- inception_marketValue: 18471.460509309396
- latNavDate: 2026-03-31
- prodcode: SHGR
- plancode: GR
- optioncode: G
- amfi_schcode: 150445
- cmt_schcode: 42978
- isin: INF247L01BB1
-
-
benchmarkreturns:
-
0:
- type: BM
- groupName: BSE Healthcare TRI (PRIMARY)
- latNavDate: 2026-03-31
- latnav: 40107.94
- oneYear_Ret: 0.0
- threeYear_Ret: 17.098990168721073
- inception_Ret: 12.517196037367428
- bmcode: 2046.0
-
*Investors should consult their financial advisers if in doubt about whether the product is suitable for them
Past Performance Calculator
Explore how much wealth you would have created by investing in our schemes using this SIP Calculator
Search a fund
Motilal Oswal Mid cap fund
SIP
Lumpsum
If you would have invested monthly
If you would have invested
10000
Tenure
10
Invested Amount
1200000
Current Value of Investment
Disclaimer:
- This calculator is provided for informational purposes only.
- The results are based on user inputs and should not be considered as investment advice. Users should seek the advice of a qualified financial professional before making any investment decisions.
- The creators of the calculator and its affiliates shall not be held responsible for any financial losses resulting from the use of the calculator.
- Past performance may or may not be sustained in the future and should not be used as a basis for comparison with other investments. Mutual Fund Investments are subject to market risks, read all scheme related documents carefully.
- SIP is allowed in select open ended schemes. Refer the Scheme SAI, SID, KIM for detailed information.
Why this fund?
Expertise
Backed by a decade of financial expertise, we focus on long-term wealth creation through early investment in promising midcaps.
High Conviction
A focused portfolio of ~35 high-conviction midcap stocks, carefully selected for their unique potential.
Quality and Growth
We prioritize business quality and management strength, guided by our QGLP investment philosophy.
*Based upon our current investment strategy.
Pioneering Growth
A House known for identifying high-growth themes that serve as compounding instruments & stand as formidable wealth creators.
Skin in the Game
Our promoters have invested a substantial ~71772 Cr.*, firmly aligning our interests with yours.
*Data as on 31st January 2024.
Disclaimer: The investment objective of the Scheme is to achieve long term capital appreciation by predominantly investing in equity.
Portfolio Composition
Download
-
Date As On: 31 Mar 2026
-
portfolioUrl: /content/dam/motilal-mf/sheets/fund-csvs/Month_End_Portfolio_February_2026/YO36.xlsx
-
holdings:
-
0:
- srNo: 1
- nameOfSecurity: Sun Pharmaceutical Industries Limited
- percentToNAV: 13.46%
-
1:
- srNo: 2
- nameOfSecurity: Divi's Laboratories Limited
- percentToNAV: 5.99%
-
2:
- srNo: 3
- nameOfSecurity: Max Healthcare Institute Limited
- percentToNAV: 5.92%
-
3:
- srNo: 4
- nameOfSecurity: Apollo Hospitals Enterprise Limited
- percentToNAV: 5.86%
-
4:
- srNo: 5
- nameOfSecurity: Dr. Reddy's Laboratories Limited
- percentToNAV: 5.75%
-
5:
- srNo: 6
- nameOfSecurity: Cipla Limited
- percentToNAV: 5.59%
-
6:
- srNo: 7
- nameOfSecurity: Lupin Limited
- percentToNAV: 4.09%
-
7:
- srNo: 8
- nameOfSecurity: Fortis Healthcare Limited
- percentToNAV: 3.60%
-
8:
- srNo: 9
- nameOfSecurity: Torrent Pharmaceuticals Limited
- percentToNAV: 3.34%
-
9:
- srNo: 10
- nameOfSecurity: Laurus Labs Limited
- percentToNAV: 3.06%
-
10:
- srNo: 11
- nameOfSecurity: Aurobindo Pharma Limited
- percentToNAV: 2.50%
-
11:
- srNo: 12
- nameOfSecurity: Alkem Laboratories Limited
- percentToNAV: 2.42%
-
12:
- srNo: 13
- nameOfSecurity: Glenmark Pharmaceuticals Limited
- percentToNAV: 2.35%
-
13:
- srNo: 14
- nameOfSecurity: Biocon Limited
- percentToNAV: 2.04%
-
14:
- srNo: 15
- nameOfSecurity: Mankind Pharma Limited
- percentToNAV: 1.84%
-
15:
- srNo: 16
- nameOfSecurity: Zydus Lifesciences Limited
- percentToNAV: 1.70%
-
16:
- srNo: 17
- nameOfSecurity: IPCA Laboratories Limited
- percentToNAV: 1.57%
-
17:
- srNo: 18
- nameOfSecurity: Krishna Institute Of Medical Sciences Limited
- percentToNAV: 1.36%
-
18:
- srNo: 19
- nameOfSecurity: JB Chemicals & Pharmaceuticals Limited
- percentToNAV: 1.23%
-
19:
- srNo: 20
- nameOfSecurity: Aster DM Healthcare Limited
- percentToNAV: 1.12%
-
20:
- srNo: 21
- nameOfSecurity: Gland Pharma Limited
- percentToNAV: 1.06%
-
21:
- srNo: 22
- nameOfSecurity: Abbott India Limited
- percentToNAV: 1.03%
-
22:
- srNo: 23
- nameOfSecurity: Sai Life Sciences Limited
- percentToNAV: 1.00%
-
23:
- srNo: 24
- nameOfSecurity: Ajanta Pharma Limited
- percentToNAV: 0.93%
-
24:
- srNo: 25
- nameOfSecurity: Narayana Hrudayalaya Limited
- percentToNAV: 0.91%
-
25:
- srNo: 26
- nameOfSecurity: Wockhardt Limited
- percentToNAV: 0.83%
-
26:
- srNo: 27
- nameOfSecurity: Acutaas Chemicals Limited
- percentToNAV: 0.82%
-
27:
- srNo: 28
- nameOfSecurity: Neuland Laboratories Limited
- percentToNAV: 0.81%
-
28:
- srNo: 29
- nameOfSecurity: Dr. Lal Path Labs Limited
- percentToNAV: 0.79%
-
29:
- srNo: 30
- nameOfSecurity: GlaxoSmithKline Pharmaceuticals Limited
- percentToNAV: 0.77%
-
30:
- srNo: 31
- nameOfSecurity: Piramal Pharma Limited
- percentToNAV: 0.70%
-
31:
- srNo: 32
- nameOfSecurity: Global Health Limited
- percentToNAV: 0.70%
-
32:
- srNo: 33
- nameOfSecurity: Natco Pharma Limited
- percentToNAV: 0.65%
-
33:
- srNo: 34
- nameOfSecurity: Granules India Limited
- percentToNAV: 0.62%
-
34:
- srNo: 35
- nameOfSecurity: Syngene International Limited
- percentToNAV: 0.59%
-
35:
- srNo: 36
- nameOfSecurity: Pfizer Limited
- percentToNAV: 0.56%
-
36:
- srNo: 37
- nameOfSecurity: Onesource Specialty Pharma Limited
- percentToNAV: 0.53%
-
37:
- srNo: 38
- nameOfSecurity: Jubilant Pharmova Limited
- percentToNAV: 0.51%
-
38:
- srNo: 39
- nameOfSecurity: Dr Agarwals Health Care Limited
- percentToNAV: 0.46%
-
39:
- srNo: 40
- nameOfSecurity: Rainbow Childrens Medicare Limited
- percentToNAV: 0.43%
-
40:
- srNo: 41
- nameOfSecurity: Strides Pharma Science Limited
- percentToNAV: 0.41%
-
41:
- srNo: 42
- nameOfSecurity: Eris Lifesciences Limited
- percentToNAV: 0.41%
-
42:
- srNo: 43
- nameOfSecurity: AstraZeneca Pharma India Limited
- percentToNAV: 0.41%
-
43:
- srNo: 44
- nameOfSecurity: Indegene Limited
- percentToNAV: 0.38%
-
44:
- srNo: 45
- nameOfSecurity: Cohance Lifesciences Limited
- percentToNAV: 0.36%
-
45:
- srNo: 46
- nameOfSecurity: Metropolis Healthcare Limited
- percentToNAV: 0.36%
-
46:
- srNo: 47
- nameOfSecurity: Poly Medicure Limited
- percentToNAV: 0.36%
-
47:
- srNo: 48
- nameOfSecurity: Vijaya Diagnostic Centre Limited
- percentToNAV: 0.36%
-
48:
- srNo: 49
- nameOfSecurity: Jupiter Life Line Hospitals Limited
- percentToNAV: 0.34%
-
49:
- srNo: 50
- nameOfSecurity: Emcure Pharmaceuticals Limited
- percentToNAV: 0.32%
-
50:
- srNo: 51
- nameOfSecurity: Concord Biotech Limited
- percentToNAV: 0.30%
-
51:
- srNo: 52
- nameOfSecurity: Alembic Pharmaceuticals Limited
- percentToNAV: 0.29%
-
52:
- srNo: 53
- nameOfSecurity: Procter & Gamble Health Limited
- percentToNAV: 0.29%
-
53:
- srNo: 54
- nameOfSecurity: Aarti Pharmalabs Limited
- percentToNAV: 0.27%
-
54:
- srNo: 55
- nameOfSecurity: Marksans Pharma Limited
- percentToNAV: 0.27%
-
55:
- srNo: 56
- nameOfSecurity: Shilpa Medicare Limited
- percentToNAV: 0.27%
-
56:
- srNo: 57
- nameOfSecurity: Sanofi India Limited
- percentToNAV: 0.26%
-
57:
- srNo: 58
- nameOfSecurity: Caplin Point Laboratories Limited
- percentToNAV: 0.25%
-
58:
- srNo: 59
- nameOfSecurity: Sanofi Consumer Healthcare India Limited
- percentToNAV: 0.22%
-
59:
- srNo: 60
- nameOfSecurity: Healthcare Global Enterprises Limited
- percentToNAV: 0.21%
-
60:
- srNo: 61
- nameOfSecurity: Alivus Life Sciences Limited
- percentToNAV: 0.21%
-
61:
- srNo: 62
- nameOfSecurity: Yatharth Hospital And Trauma Care Services Limited
- percentToNAV: 0.19%
-
62:
- srNo: 63
- nameOfSecurity: Viyash Scientific Limited
- percentToNAV: 0.18%
-
63:
- srNo: 64
- nameOfSecurity: Kovai Medical Center and Hospital Limited
- percentToNAV: 0.18%
-
64:
- srNo: 65
- nameOfSecurity: Senores Pharmaceuticals Limited
- percentToNAV: 0.15%
-
65:
- srNo: 66
- nameOfSecurity: Thyrocare Technologies Limited
- percentToNAV: 0.13%
-
66:
- srNo: 67
- nameOfSecurity: Indraprastha Medical Corporation Limited
- percentToNAV: 0.13%
-
67:
- srNo: 68
- nameOfSecurity: FDC Limited
- percentToNAV: 0.13%
-
68:
- srNo: 69
- nameOfSecurity: Supriya Lifescience Limited
- percentToNAV: 0.12%
-
69:
- srNo: 70
- nameOfSecurity: Morepen Laboratories Limited
- percentToNAV: 0.11%
-
70:
- srNo: 71
- nameOfSecurity: Advanced Enzyme Technologies Limited
- percentToNAV: 0.11%
-
71:
- srNo: 72
- nameOfSecurity: Blue Jet Healthcare Ltd
- percentToNAV: 0.10%
-
72:
- srNo: 73
- nameOfSecurity: Bliss GVS Pharma Limited
- percentToNAV: 0.10%
-
73:
- srNo: 74
- nameOfSecurity: Solara Active Pharma Sciences Limited
- percentToNAV: 0.10%
-
74:
- srNo: 75
- nameOfSecurity: Aarti Drugs Limited
- percentToNAV: 0.10%
-
75:
- srNo: 76
- nameOfSecurity: Akums Drugs and Pharmaceuticals Limited
- percentToNAV: 0.10%
-
76:
- srNo: 77
- nameOfSecurity: Sun Pharma Advanced Research Company Limited
- percentToNAV: 0.09%
-
77:
- srNo: 78
- nameOfSecurity: Krsnaa Diagnostics Limited
- percentToNAV: 0.08%
-
78:
- srNo: 79
- nameOfSecurity: Dishman Carbogen Amcis Limited
- percentToNAV: 0.08%
-
79:
- srNo: 80
- nameOfSecurity: SMS Pharmaceuticals Limited
- percentToNAV: 0.08%
-
80:
- srNo: 81
- nameOfSecurity: Innova Captab Limited
- percentToNAV: 0.08%
-
81:
- srNo: 82
- nameOfSecurity: Gujarat Themis Biosyn Limited
- percentToNAV: 0.07%
-
82:
- srNo: 83
- nameOfSecurity: Orchid Pharma Limited
- percentToNAV: 0.07%
-
83:
- srNo: 84
- nameOfSecurity: Suven Life Sciences Limited
- percentToNAV: 0.07%
-
84:
- srNo: 85
- nameOfSecurity: IOL Chemicals and Pharmaceuticals Limited
- percentToNAV: 0.06%
-
85:
- srNo: 86
- nameOfSecurity: RPG Life Sciences Limited
- percentToNAV: 0.06%
-
86:
- srNo: 87
- nameOfSecurity: Gufic Biosciences Limited
- percentToNAV: 0.06%
-
87:
- srNo: 88
- nameOfSecurity: Indoco Remedies Limited
- percentToNAV: 0.05%
-
88:
- srNo: 89
- nameOfSecurity: Hikal Limited
- percentToNAV: 0.05%
-
89:
- srNo: 90
- nameOfSecurity: Kwality Pharmaceuticals Limited
- percentToNAV: 0.05%
-
90:
- srNo: 91
- nameOfSecurity: Unichem Laboratories Limited
- percentToNAV: 0.05%
-
91:
- srNo: 92
- nameOfSecurity: Artemis Medicare Services Limited
- percentToNAV: 0.05%
-
92:
- srNo: 93
- nameOfSecurity: Vimta Labs Limited
- percentToNAV: 0.05%
-
93:
- srNo: 94
- nameOfSecurity: 3B BlackBio Dx Limited
- percentToNAV: 0.05%
-
94:
- srNo: 95
- nameOfSecurity: Lincoln Pharmaceuticals Limited
- percentToNAV: 0.05%
-
95:
- srNo: 96
- nameOfSecurity: Windlas Biotech Limited
- percentToNAV: 0.04%
-
96:
- srNo: 97
- nameOfSecurity: Novartis India Limited
- percentToNAV: 0.04%
-
97:
- srNo: 98
- nameOfSecurity: Hester Biosciences Limited
- percentToNAV: 0.04%
-
98:
- srNo: 99
- nameOfSecurity: Syncom Formulations India Limited
- percentToNAV: 0.04%
-
99:
- srNo: 100
- nameOfSecurity: Dr.Agarwals Eye Hospital Limited
- percentToNAV: 0.04%
-
100:
- srNo: 101
- nameOfSecurity: Panacea Biotec Limited
- percentToNAV: 0.04%
-
101:
- srNo: 102
- nameOfSecurity: Suraksha Diagnostic Limited
- percentToNAV: 0.04%
-
102:
- srNo: 103
- nameOfSecurity: Wanbury Limited
- percentToNAV: 0.04%
-
103:
- srNo: 104
- nameOfSecurity: Fischer Medical Ventures Limited
- percentToNAV: 0.04%
-
104:
- srNo: 105
- nameOfSecurity: Bajaj Healthcare Limited
- percentToNAV: 0.03%
-
105:
- srNo: 106
- nameOfSecurity: Shalby Limited
- percentToNAV: 0.03%
-
106:
- srNo: 107
- nameOfSecurity: Sigachi Industries Limited
- percentToNAV: 0.03%
-
107:
- srNo: 108
- nameOfSecurity: Laxmi Dental Limited
- percentToNAV: 0.03%
-
108:
- srNo: 109
- nameOfSecurity: Kopran Limited
- percentToNAV: 0.03%
-
109:
- srNo: 110
- nameOfSecurity: GPT Healthcare Limited
- percentToNAV: 0.03%
-
110:
- srNo: 111
- nameOfSecurity: KMC Speciality Hospitals (India) Limited
- percentToNAV: 0.02%
-
111:
- srNo: 112
- nameOfSecurity: Fermenta Biotech Limited
- percentToNAV: 0.02%
-
112:
- srNo: 113
- nameOfSecurity: Jagsonpal Pharmaceuticals Limited
- percentToNAV: 0.02%
-
113:
- srNo: 114
- nameOfSecurity: Tarsons Products Limited
- percentToNAV: 0.02%
-
114:
- srNo: 115
- nameOfSecurity: Themis Medicare Limited
- percentToNAV: 0.02%
-
115:
- srNo: 116
- nameOfSecurity: Sastasundar Ventures Limited
- percentToNAV: 0.02%
-
116:
- srNo: 117
- nameOfSecurity: Anuh Pharma Limited
- percentToNAV: 0.02%
-
117:
- srNo: 118
- nameOfSecurity: Shree Ganesh Remedies Limited
- percentToNAV: 0.01%
-
118:
- srNo: 119
- nameOfSecurity: Nectar Lifesciences Limited
- percentToNAV: 0.01%
-
-
sector:
-
0:
- sector: Pharmaceuticals & Biotechnology
- percentage: 74.92%
-
1:
- sector: Healthcare Services
- percentage: 24.49%
-
2:
- sector: Healthcare Equipment & Supplies
- percentage: 0.44%
-
3:
- sector: Cash & Equivalent
- percentage: 0.16%
-
Industry Classification as recommended by AMFI
-
-
Key Facts
- Launched on 06 Feb 2024
-
Investment Objective
-
trackingerror:0.03 % (From 11 Mar 2025 to 10 Mar 2026)
-
methodology:
a) Methodology of calculating sale price: The price or NAV, an investor is charged while investing in anopen-ended scheme is called sale or subscription price. Pursuant toSEBI Circular dated June 30, 2009, no entry load will be chargedby the scheme to the investors. Therefore, Sale or Subscriptionprice = Applicable NAV (for respective plan and option of thescheme)
Example: An investor invests Rs.10,000/- and the current NAV isRs. 10/- then the purchase price will be Rs.10/- and the investorreceives 10,000/10 = 1000 units.
b) Methodology of calculating repurchase price of Units: Repurchase or redemption price is the price or NAV at which anopen-ended scheme purchases or redeems its units from theinvestors. It may include exit load, if applicable. The exit load, ifany, shall be charged as a percentage of Net Assets Value (NAV)i.e. applicable load as a percentage of NAV will be deducted fromthe ÒApplicable NAVÓ to calculate the repurchase price.Therefore, Repurchase or Redemption Price = Applicable NAV*(1- Exit Load, if any)
Example: If the Applicable NAV is Rs. 10 and a 2% Exit Load ischarged, the Redemption Price per Unit will be calculated asfollows: = Rs. 10 * (1-0.02) = Rs. 10 * (0.98) = Rs. 9.80
-
indexMethodology:
Index Methodology: Click here
Historic Changes in Index Constituents: Click here
-
investmentObjective:
The investment objective of the scheme is to provide returns that, before expenses, correspond to the total returns of the securities as represented by BSE Healthcare TRI, subject to tracking error. However, there is no guarantee or assurance that the investment objective of the scheme will be achieved.
-
applicationAmount:
NA
-
redemptionAmont: NA
-
exitLoad:
-
aum:
-
0:
- latestAum: 40.6761
- latestAumAsOnDt: 2026-03-31T00:00:00
- optioncode: G
- plancode: GR
- prodcode: SHGR
-
-
portfolioTurnoverRatio: 0.16
-
planList:
-
0:
- groupedName: Regular-Growth
- planName: Regular
- optionCode: G
- groupedCode: GRG
- planNameOriginal: Regular Growth
- planCode: GR
- sixth_char_name: R
- optionName: Growth
- schDetail:
- fundCategoryCode:
- cfReferencePath: /content/dam/motilal-mf/content-fragment/plan-code-model-fragment/regular-growth-etf
- isin: INF247L01BB1
- amfi_schcode: 150445
- cmt_schcode: 42978
-
-
benchmark: BSE Healthcare Total Return Index
-
expenseRatioDirect: 0.24% p.a.
-
benchmarkreturns:
-
0:
- type: BM
- groupName: BSE Healthcare TRI (PRIMARY)
- latNavDate: 2026-03-31
- latnav: 40107.94
- oneYear_Ret: 0.0
- threeYear_Ret: 17.098990168721073
- inception_Ret: 12.517196037367428
- bmcode: 2046.0
-
Minimum Application Amount
₹500/- and in multiples of ₹1/- thereafter
Minimum Redemption Amount
₹500/- then ₹1/- increments, up to account balance
Latest AUM
40.6761
2026-03-31T00:00:00
Portfolio Turnover Ratio
0.16
Plans
Regular
Options (Under each plan)
Growth
Benchmark
BSE Healthcare Total Return Index
Total Expense Ratio
0.24% p.a.
Inception date
2026-03-31
Entry Load
Exit Load Policy
Our Fund Managers
Managing this fund since
Total AUM
-
-
schDetail
- cmotsGroupCode: MO42978
- nfoStartDate: 13-Jul-2022
- dateOfAllotment: 2022-07-29
- sebiCategory: ETF Fund
- schemeName: Motilal Oswal Bse Healthcare Etf
- nfoEndDate: 21-Jul-2022
- fundCategoryCode: ETF
- schcode: SH
-
fundManager:
-
0:
-
picture: /content/dam/motilal-mf/fund-manager/mr-swapnil-mayekar.png
-
type: MF
-
designation: Fund Manager
-
description:
Swapnil has over 12 years of experience in the fund management and product development.
Motilal Oswal Asset Management Company Ltd. from March 2010 onwards.
Business Standard, Research Associate from August 2005 to February 2010.
-
fundManagerName: Swapnil Mayekar
-
dropdownField: MF
-
cfReferencePath: /content/dam/motilal-mf/content-fragment/fund-manager/swapnil-mayekar
-
-
1:
-
picture: /content/dam/motilal-mf/fund-manager/mr-rakesh-shetty.png
-
type: MF
-
designation: Fund Manager/Dealer
-
description:
Mr. Rakesh Shetty has more than 13 years of overall experience and expertise in trading in equity, debt segment, Exchange Trade Fund’s management, Corporate Treasury and Banking. Prior to joining Motilal Oswal Asset Management Company Limited, he has worked with Company engaged in Capital Market Business wherein he was in charge of equity and debt ETFs, customized indices and has also been part of product development.
-
fundManagerName: Rakesh Shetty
-
dropdownField: MF
-
cfReferencePath: /content/dam/motilal-mf/content-fragment/fund-manager/rakesh-shetty
-
-
2:
-
picture: /content/dam/motilal-mf/fund-manager/mr-dishant-mehta.png
-
type: MF
-
designation: Manager, Associate Fund Manager and Passive Dealer
-
description:
Mr. Dishant Mehta has more than 11 years of experience and expertise in Financial markets across different segment -Equities, Derivatives, Commodities and Currencies. Managed Institutional and Foreign Portfolio Investment clients. Prior to joining Motilal Oswal Asset Management Company, Mr. Mehta has worked with Emkay Global Financial Services Limited, Anand Rathi Shares & Stock Brokers Limited, Kotak Securities Limited and Angel Broking Limited.
-
fundManagerName: Dishant Mehta
-
dropdownField: MF
-
cfReferencePath: /content/dam/motilal-mf/content-fragment/fund-manager/dishant-mehta
-
-
Downloads
-
- Factsheet
-
- Presentation
-
- Brochures
-
- Scheme information document
-
- Forms
-
- Index Component
- portfolioUrl/content/dam/motilal-mf/sheets/fund-csvs/Month_End_Portfolio_February_2026/YO36.xlsx
- brochurepdf/content/dam/motilal-mf/downloads/mf/leafletsbrochures/2026/mar/e0edd-index-fund-brochure-rd-feb-2026_compressed-1-.pdf
- latestFactsheetPdf/content/dam/motilal-mf/downloads/mf/factsheet/2026/mar/37a03-most-factsheet-february-2026-passive.pdf
- presentationPdf/content/dam/motilal-mf/downloads/mf/presentations/2026/jan/36a18-presentation-motilal-oswal-bse-healthcare-etf-dec-2025.pdf
- sidDocumentPdf/content/dam/motilal-mf/downloads/mf/sid/2025/nov/9002b-sid_motilal-oswal-bse-healthcare-etf.pdf
- formPdf
- indexComponent/content/dam/motilal-mf/sheets/index-component/SH.xlsx
Frequently Asked Questions
Are ETFs a good investment?
How can beginners invest in ETFs?
Can I buy and sell ETFs anytime?
How much money do I need to start investing in ETFs?
Is it better to invest in ETFs for the short-term or long-term?
Can I start a SIP in an ETF?
What is the average return on ETFs in India?
Is ETF taxable in India?
What is better, ETF or mutual funds?
What is the entry/exit load for ETFs?
How to buy ETF?
Do ETFs pay dividends?
Is ETF an active or a passive fund?
Product Label
This product is suitable for investors who are seeking*
- Long term capital growth
- Investments in equity and equity related instruments of large cap stocks.
*Investors should consult their financial advisers if in doubt about whether the product is suitable for them.
-
productLabellingDescription:
This product is suitable for investors who are seeking*
- Return that corresponds to the performance of BSE Healthcare Total Return Index subject to tracking error.
- Long term capital growth.
-
benchmarkreturns:
-
0:
- type: BM
- groupName: BSE Healthcare TRI (PRIMARY)
- latNavDate: 2026-03-31
- latnav: 40107.94
- oneYear_Ret: 0.0
- threeYear_Ret: 17.098990168721073
- inception_Ret: 12.517196037367428
- bmcode: 2046.0
-
-
schDetail
- cmotsGroupCode: MO42978
- nfoStartDate: 13-Jul-2022
- dateOfAllotment: 2022-07-29
- sebiCategory: ETF Fund
- schemeName: Motilal Oswal Bse Healthcare Etf
- nfoEndDate: 21-Jul-2022
- fundCategoryCode: ETF
- schcode: SH
-
risk
- riskType: Very High
- benchmarkRisk: Very High
- Motilal Oswal Asset Allocation Passive Fund Conservative
Invest Now